Médunik Canada research project published in Journal Les Affaires

Médunik Canada in the spotlight of Les Affaires. One of six entities of Duchesnay Pharmaceutical Group announces the launch of a research project on multiple sclerosis in partnership with the Population Council, a renowned research organization based in the USA. To learn more about this initiative, read the article at the following link (in French only): Médunik Canada investit en R&D pour la sclérose en plaques